Acadia will definitely open a study on the autism spectrum. perhaps with 2591 through a partnership financed by the BB perhaps with something else.he would not have started a couple of exploratory trials to investigate irritability on specific autism associated with Pimavanserin. Trial that will end in the same period in which fundamental decisions will be made on 2591 or other....If I can add my feeling, I think a trial with Acadia on PMD and Angelman is very likely. another question for PItt and even more so PW.
https://classic.clinicaltrials.gov/ct2/show/NCT05523895?term=acadia+pharmaceutical&draw=3&rank=16
Acadia will definitely open a study on the autism spectrum....
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.25 |
Change
0.000(0.00%) |
Mkt cap ! $2.585B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 841 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.24 | 516 | 3 |
View Market Depth
| Last trade - 09.49am 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.37 |
Change
0.000 ( 0.68 %) |
||||
| Open | High | Low | Volume | ||
| $20.45 | $20.50 | $20.37 | 191 | ||
| Last updated 10.11am 08/05/2024 ? | |||||
| NEU (ASX) Chart |
Day chart unavailable